We use cookies for a better user experience. Read our Privacy Policy

I Agree

Autologous Matrix-induced Chondrogenesis Market Forecast Report, 2016-2024

Autologous Matrix-induced Chondrogenesis Market (Material - Hyaluronic Acid, Collagen, Polyethylene Glycol (PEG), and Poly Lactic-Co-Glycolic Acid (PGLA)) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Global Autologous Matrix-induced Chondrogenesis Market: Overview

Rise in the inclination among patients toward non-invasive surgeries is anticipated to boost the sales growth in the global autologous matrix-induced chondrogenesis market. Hence, the market for autologous matrix-induced chondrogenesis is prognosticated to expand at a CAGR of 8.6% during the forecast period of 2016 to 2024 and reach a valuation of US$186.38 Mn by 2024.

A report by Transparency Market Research (TMR) delivers panoramic view of the global autologous matrix-induced chondrogenesis market. Hence, readers are provided comprehensive assessment of major crucial factors such as growth drivers, expansion opportunities, investment avenues, demand-supply ratio, challenges, restraints, and key regions of the market for autologous matrix-induced chondrogenesis.

The analysts of study by TMR have performed the segmentation of the global autologous matrix-induced chondrogenesis market based on several crucial parameters such as material and region. In terms of material, the market is divided into many parts such as collagen, hyaluronic acid, poly lactic-co-glycolic acid (PGLA), and polyethylene glycol (PEG), and others.

autologous matrix induced chondrogenesis market

Rise in Use of Collagen in Tissue Engineering Applications Fuels Prospects in Autologous Matrix-Induced Chondrogenesis Market

A human body comprises of about 30% collagen of all protein. Thus, collagen is used in a wide range of tissue engineering applications. In addition, it is gaining traction owing to its numerous advantages such as excellent handling properties and high tensile strength. These factors shows that the collagen segment of the global autologous matrix-induced chondrogenesis market is likely to offer revenue-generation opportunities in the years ahead.

The global autologous matrix-induced chondrogenesis market is estimated to be propelled by several important factors such as a surge in number of older populace across the globe and increase in understanding on the availability of autologous matrix-induced chondrogenesis techniques.

Increase in Prevalence of Bone and Joint Disorders Drives Demand Prospects in Market

Microfracture surgeries are considered one of the efficient techniques for the repair of articular cartilage injury. In these surgeries, autologous matrix-induced chondrogenesis (AMIC) utilize bi-layer collagen membrane. Hence, increase in number of patients dealing with bone and joint disorders are expected to propel the autologous matrix-induced chondrogenesis market in the forecast period.

North America Market to Expand owing to Rise in Older Population in Region

Several important regions studied in the TMR report on the global autologous matrix-induced chondrogenesis market include Europe, North America, Latin America, Middle East and Africa, and Asia Pacific. Among all regions, North America holds major share of the market.

In North America, there is a notable increase in number of older population, which is at higher risk of different health issues including bone and joint disorders. Hence, the autologous matrix-induced chondrogenesis market is prognosticated to experience high revenue-generation opportunities in North America with rising prevalence of several diseases pertaining to bone and joints, including rheumatoid arthritis and arthritis, among older population.

Companies Develop Breakthrough Products, Increase Investments in R&Ds

The nature of the global autologous matrix-induced chondrogenesis market is fairly consolidated with a few companies holding major share of the global market. Hence, the competition levels in the market are highly intense. Players are using organic and inorganic strategies in order to sustain in this competition.

Players operating in the autologous matrix-induced chondrogenesis market are focused on the expansion of businesses in several developing nations. Moreover, are investing heavily in R&D projects in order to develop and launch breakthrough products. These initiatives are estimated to work in favor of the global autologous matrix-induced chondrogenesis market in the forecast period.

Some key players operating in the autologous matrix-induced chondrogenesis market include BioTissue AG, JRI Orthopaedics Ltd., B. Braun Melsungen AG, Anika Therapeutics, Inc., Geistlich Pharma AG, Arthro-Kinetics, Smith & Nephew plc, Zimmer Biomet Holdings, and CartiHeal, Matricel GmbH.

Enterprises in the autologous matrix-induced chondrogenesis market are developing strong policies in order to sustain their businesses in unfavorable situations they are facing owing to the COVID-19 outbreak. They are focused on continuing on their regular activities while following all safety norms implemented by the regional government bodies.

The global autologous matrix-induced chondrogenesis market has been segmented as follows:

by Material

  • Hyaluronic Acid
  • Collagen
  • Polyethylene Glycol (PEG)
  • Poly lactic-co-glycolic acid (PGLA
  • Others

by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa
Autologous Matrix-induced Chondrogenesis Market Forecast Report, 2016-2024

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of Autologous Matrix-induced Chondrogenesis Market?

Autologous Matrix-induced Chondrogenesis Market was worth US$89.71 mn and is projected to reach a value of US$186.38 mn by the end of 2024

What is the anticipated CAGR of the Autologous Matrix-induced Chondrogenesis Market in the forecast period?

Autologous Matrix-induced Chondrogenesis Market is anticipated to grow at a CAGR of 8.60% during the forecast period

Which region is expected to project the highest market share in the global Autologous Matrix-induced Chondrogenesis Market?

North America accounted for a major share of the global Autologous Matrix-induced Chondrogenesis Market

What are the key driving factors for the growth of the Autologous Matrix-induced Chondrogenesis Market?

Rise in the inclination among patients toward non-invasive surgeries are driving the growth factors of Autologous Matrix-induced Chondrogenesis Market

Who are the key players in the global Autologous Matrix-induced Chondrogenesis Market?

Key players in the global Autologous Matrix-induced Chondrogenesis Market include BioTissue AG, JRI Orthopaedics Ltd., B. Braun Melsungen AG, Anika Therapeutics, Inc., Geistlich Pharma AG, Arthro-Kinetics, Smith & Nephew plc, Zimmer Biomet Holdings, and CartiHeal, Matricel GmbH.

Section - 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section - 2 Assumptions and Research Methodology 
2.1 Assumptions and Acronyms Used
2.2 Research Methodology

Section-3 Executive Summary
3.1 Global AMIC Market: Market Snapshot
3.2 Global AMIC Market : Opportunity Map

Section-4 Market Overview
4.1 Global AMIC Market : Key Industry Developments

Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
      5.1.2 Drivers
              5.1.2.1 Increasing Demand for Minimally Invasive Procedures
              5.1.2.2 Economically Efficient
              5.1.2.3 Rising Prevalence of Bone and Joint Disorders
              5.1.2.4 Aging Population
              5.1.2.5 Surge in Sports Injuries
              5.1.2.6 Reduces Life Risk and Faster Recovery
      5.1.3 Restraints
              5.1.3.1 Lack of Efficient Reimbursement System 
              5.1.3.2 Lack of Extensive Clinical Data
      5.1.4 Opportunity Analysis
              5.1.4.1 Emerging Economies to Offer Sustained Growth Opportunities
              5.1.4.2 Extending Distribution Network by Partnership/Acquisitions
5.2 Global AMIC Market Revenue Projection
5.3 Porter’s Five Forces Analysis
5.4 Value Chain Analysis
5.5 AMIC Market Outlook

Section-6 AMIC Market Analysis By Material
6.1 Key Findings
6.2 Introduction
6.3 Global AMIC Market Value Share Analysis, By Product Type
6.4 Global AMIC Market Forecast By Product Type
      6.4.1 Hyaluronic Acid
      6.4.2 Collagen
      6.4.3 Polyethylene glycol (PEG)
      6.4.4 Poly lactic-co-glycolic acid (PGLA)
      6.4.5 Others
6.5 Global AMIC Market Attractiveness Analysis By Material

Section-7 Global AMIC Market Analysis By Region
7.1 Global Regulatory Scenario
7.2 Global AMIC Market Value Share Analysis, By Region
7.3 Global AMIC Market Forecast, By Region
7.4 Global AMIC Market Attractiveness Analysis, By Region Type

Section-8 North America AMIC Market Analysis
8.1 Key Findings
8.2 North America AMIC Market Overview
8.3 North America Market Value Share Analysis, By Material
      8.3.1 North America Market Forecast By Material
8.4 North America Market Forecast By Country
8.5 North America Market Attractiveness Analysis
8.6 North America Market Trends

Section-9 Europe AMIC Market Analysis
9.1 Key Findings
9.2 Europe ABC Market Overview
9.3 Europe Market Value Share Analysis, By Material
      9.3.1 Europe Market Forecast By Material
9.4 Europe Market Forecast By Country
9.5 Europe Market Attractiveness Analysis
9.6 Europe Market Trends

Section-10 Asia Pacific AMIC Market Analysis
10.1 Key Findings
10.2 Asia Pacific AMIC Market Overview
10.3 Asia Pacific Market Value Share Analysis, By Material
      10.3.1 Asia Pacific Market Forecast By Material
10.4 Asia Pacific Market Forecast By Country
10.5 Asia Pacific Market Attractiveness Analysis
10.6 Asia Pacific Market Trends

Section-11 Latin America AMIC Market Analysis
11.1 Key Findings
11.2 Latin America AMIC Market Overview
11.3 Latin America Market Value Share Analysis, By Material
      11.3.1 Latin America Market Forecast By Material
11.4 Latin America Market Forecast By Country
11.5 Latin America Market Attractiveness Analysis
11.6 Latin America Market Trends

Section-12 Middle East and Africa AMIC Market Analysis
12.1 Key Findings
12.2 Middle East and Africa AMIC Market Overview
12.3 Middle East and Africa Market Value Share Analysis, By Material
      12.3.1 Middle East and Africa Market Forecast By Material
12.4 Middle East and Africa Market Forecast By Country
12.5 Middle East and Africa Market Attractiveness Analysis

Section-13 Competition Landscape
13.1. Competition Matrix
13.2. Company Profiles
      13.2.1. Anika Therapeutics, Inc. 
              13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
              13.2.1.2. Financial Overview
              13.2.1.3. Product Portfolio
              13.2.1.4. SWOT Analysis
              13.2.1.5. Strategic Overview
      13.2.2 Arthro-Kinetics
              13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
              13.2.2.2. Financial Overview
              13.2.2.3. Product Portfolio
              13.2.2.4. SWOT Analysis
              13.2.2.5. Strategic Overview
              13.2.3 B. Braun Melsungen AG 
              13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
              13.2.3.2. Financial Overview
              13.2.3.3. Product Portfolio
              13.2.3.4. SWOT Analysis
              13.2.3.5. Strategic Overview
      13.2.4 BioTissue AG 
              13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
              13.2.4.2. Financial Overview
              13.2.4.3. Product Portfolio
              13.2.4.4. SWOT Analysis
              13.2.4.5. Strategic Overview
      13.2.5 CartiHeal
              13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
              13.2.5.2. Financial Overview
              13.2.5.3. Product Portfolio
              13.2.5.4. SWOT Analysis
              13.2.5.5. Strategic Overview
      13.2.6 Geistlich Pharma AG 
              13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
              13.2.6.2. Financial Overview
              13.2.6.3. Product Portfolio
              13.2.6.4. SWOT Analysis
              13.2.6.5. Strategic Overview
      13.2.7 JRI Orthopaedics Ltd. 
              13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
              13.2.7.2. Financial Overview
              13.2.7.3. Product Portfolio
              13.2.7.4. SWOT Analysis
              13.2.7.5. Strategic Overview
      13.2.8 Matricel GmbH
              13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
              13.2.8.2. Financial Overview
              13.2.8.3. Product Portfolio
              13.2.8.4. SWOT Analysis
              13.2.8.5. Strategic Overview
      13.2.9 Smith & Nephew plc 
              13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
              13.2.9.2. Financial Overview
              13.2.9.3. Product Portfolio
              13.2.9.4. SWOT Analysis
              13.2.9.5. Strategic Overview
      13.2.10 Zimmer Biomet Holdings
              13.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
              13.2.10.2. Financial Overview
              13.2.10.3. Product Portfolio
              13.2.10.4. SWOT Analysis
              13.2.10.5. Strategic Overview

List of Tables

Table 01: Global Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014–2024
Table 02: Global Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 03: North America Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014–2024
Table 04: North America Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 05: Europe Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014–2024
Table 06: Europe  Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 07: Asia Pacific Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014–2024
Table 08: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 09: Latin America Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014–2024
Table 10: Latin America Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 11: Middle East & Africa Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014–2024
Table 12: Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2014–2024

List of Figures

Figure 01: Global Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, 2014–2024
Figure 02: Global AMIC Market Value Share Analysis, by Material, 2016 and 2024
Figure 03: Global Hyaluronic Acid Market Revenue (US$ Mn), 2014–2024
Figure 04: Global Collagen Market Revenue (US$ Mn), 2014–2024
Figure 05: Global PEG Market Revenue (US$ Mn), 2014–2024
Figure 06: Global PGLA Market Revenue (US$ Mn), 2014–2024
Figure 07: Global Others Market Revenue (US$ Mn), 2014–2024
Figure 08: AMIC Market Attractiveness Analysis, by Material
Figure 09: Global AMIC Market Value Share Analysis, by Region, 2016 and 2024
Figure 10: AMIC Market Attractiveness Analysis, by Region
Figure 11: North America Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, 2014–2024
Figure 12: North America Autologous Matrix-Induced Chondrogenesis Market Size Y-o-Y Growth Projections, 2015–2024
Figure 13: North America Market Attractiveness Analysis, by Country
Figure 14: North America AMIC Market Value Share Analysis, by Material, 2015 and 2024
Figure 15: North America AMIC Market Value Share Analysis, by Country, 2016 and 2024
Figure 16: North America Market Attractiveness Analysis, by Material
Figure 17: Europe Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, 2014–2024
Figure 18: Europe Autologous Matrix-Induced Chondrogenesis Market Size Y-o-Y Growth Projections, 2015–2024
Figure 19: Europe Market Attractiveness Analysis, by Country
Figure 20: Europe AMIC Market Value Share Analysis, by Material, 2015 and 2024
Figure 21: Europe AMIC Market Value Share Analysis, by Country, 2015 and 2024
Figure 22: Europe AMIC Market Attractiveness Analysis, by Material
Figure 23: Asia Pacific AMIC Market Size (US$ Mn) and Forecast, 2014–2024
Figure 24: Asia Pacific AMIC Market Size Y-o-Y Growth Projections, 2015–2024
Figure 25: Asia Pacific Market Attractiveness Analysis, by Country
Figure 26: Asia Pacific AMIC Market Value Share Analysis, by Material, 2015 and 2024
Figure 27: Asia Pacific AMIC Market Value Share Analysis, by Country, 2015 and 2024
Figure 28: Asia Pacific AMIC Market Attractiveness Analysis, by Material
Figure 29: Latin America AMIC Market Size (US$ Mn) Forecast, 2014–2024
Figure 30: Latin America AMIC Market Size Y-o-Y Growth Projection, 2014–2024
Figure 31: Latin America Market Attractiveness Analysis, by Country/Region
Figure 32: Latin America AMIC Market Value Share Analysis, by Material, 2015 and 2024
Figure 33: Latin America AMIC Market Value Share Analysis, by Country, 2015 and 2024
Figure 34: Latin America AMIC Market Attractiveness Analysis, by Material
Figure 35: Middle East & Africa AMIC Market Size (US$ Mn) Forecast, 2014–2024
Figure 36: Middle East & Africa AMIC Market Size Y-o-Y Growth Projections, 2015–2024
Figure 37: Middle East & Africa Market Attractiveness Analysis, by Country
Figure 38: Middle East & Africa AMIC Market Value Share Analysis, by Material, 2015 and 2024
Figure 39: Middle East & Africa AMIC Market Value Share Analysis, by Country, 2016 and 2024
Figure 40: Middle East & Africa Market Attractiveness Analysis, by Material
Figure 41: Global Autologous Matrix-Induced Chondrogenesis Market Share Analysis By Company, (2015)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

613

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved